chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (had a 3 doses mixed primary series (first and second were Pfizer, third was Moderna)) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer (first dose, lot EN6206, expiry date 30Jun2021.) on 09-Mar-2021, Pfizer (Second dose, lot EP6955 and expiry date 30Jun2021) on 30-Mar-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. Concurrent medical conditions included Immunocompromised. Concomitant products included METHOTREXATE, GOLIMUMAB (SIMPONI), MESALAZINE (PENTASA), LAMOTRIGINE (LAMICTAL), FUROSEMIDE (LASIX [FUROSEMIDE]), ESOMEPRAZOLE MAGNESIUM (NEXIUM MUPS [ESOMEPRAZOLE MAGNESIUM]), OMEGA-3-ACID ETHYL ESTER (LOVAZA), FAMOTIDINE (PEPCID [FAMOTIDINE]) and SODIUM for an unknown indication. On 19-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (had a 3 doses mixed primary series (first and second were Pfizer, third was Moderna)). On 19-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (had a 3 doses mixed primary series (first and second were Pfizer, third was Moderna)) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medication were provided
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Lymphadenopathy, Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: Complaining of his arm hurting; Feeling off yesterday; Feeling a little tired; 16yo son got the booster; Armpit is slightly swollen (same side as; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Complaining of his arm hurting), FEELING ABNORMAL (Feeling off yesterday), FATIGUE (Feeling a little tired), LYMPHADENOPATHY (Armpit is slightly swollen (same side as) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16yo son got the booster) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced LYMPHADENOPATHY (Armpit is slightly swollen (same side as). On 17-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16yo son got the booster). On 19-Jan-2022, the patient experienced FEELING ABNORMAL (Feeling off yesterday) and FATIGUE (Feeling a little tired). On 20-Jan-2022, the patient experienced PAIN IN EXTREMITY (Complaining of his arm hurting). On 17-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16yo son got the booster) had resolved. At the time of the report, PAIN IN EXTREMITY (Complaining of his arm hurting) and LYMPHADENOPATHY (Armpit is slightly swollen (same side as) outcome was unknown and FEELING ABNORMAL (Feeling off yesterday) and FATIGUE (Feeling a little tired) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment information was provided The reporter stated that at the time of reporting the patient was feeling much better for the event  a little tired and off
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dyspnoea, Exercise tolerance decreased, Illness, Joint injury
Clinical narrative: having aches; they can not get a breath,run out of breath; joint pain; rapid health decline; got sick; never able to run with the same cardiovascular capacity; joint injuries; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (having aches), VACCINATION COMPLICATION (rapid health decline), ILLNESS (got sick), EXERCISE TOLERANCE DECREASED (never able to run with the same cardiovascular capacity) and JOINT INJURY (joint injuries) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sickness (before getting the Moderna vaccine, patient was sick but did not get tested for covid.19).    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced VACCINATION COMPLICATION (rapid health decline), ILLNESS (got sick), EXERCISE TOLERANCE DECREASED (never able to run with the same cardiovascular capacity), JOINT INJURY (joint injuries) and ARTHRALGIA (joint pain). On an unknown date, the patient experienced PAIN (having aches) and DYSPNOEA (they can not get a breath,run out of breath). At the time of the report, PAIN (having aches) had not resolved and VACCINATION COMPLICATION (rapid health decline), ILLNESS (got sick), EXERCISE TOLERANCE DECREASED (never able to run with the same cardiovascular capacity), JOINT INJURY (joint injuries), DYSPNOEA (they can not get a breath,run out of breath) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, SARS-CoV-2 test, Vaccination complication
Clinical narrative: having aches; they can not get a breath,run out of breath; joint pain; rapid health decline; got sick; never able to run with the same cardiovascular capacity; joint injuries; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (having aches), VACCINATION COMPLICATION (rapid health decline), ILLNESS (got sick), EXERCISE TOLERANCE DECREASED (never able to run with the same cardiovascular capacity) and JOINT INJURY (joint injuries) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sickness (before getting the Moderna vaccine, patient was sick but did not get tested for covid.19).    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced VACCINATION COMPLICATION (rapid health decline), ILLNESS (got sick), EXERCISE TOLERANCE DECREASED (never able to run with the same cardiovascular capacity), JOINT INJURY (joint injuries) and ARTHRALGIA (joint pain). On an unknown date, the patient experienced PAIN (having aches) and DYSPNOEA (they can not get a breath,run out of breath). At the time of the report, PAIN (having aches) had not resolved and VACCINATION COMPLICATION (rapid health decline), ILLNESS (got sick), EXERCISE TOLERANCE DECREASED (never able to run with the same cardiovascular capacity), JOINT INJURY (joint injuries), DYSPNOEA (they can not get a breath,run out of breath) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Exercise tolerance decreased, Fatigue, Malaise, Pyrexia
Clinical narrative: having aches; they can not get a breath,run out of breath; joint pain; rapid health decline; got sick; never able to run with the same cardiovascular capacity; joint injuries; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (having aches), VACCINATION COMPLICATION (rapid health decline), ILLNESS (got sick), EXERCISE TOLERANCE DECREASED (never able to run with the same cardiovascular capacity) and JOINT INJURY (joint injuries) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sickness (before getting the Moderna vaccine, patient was sick but did not get tested for covid.19).    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced VACCINATION COMPLICATION (rapid health decline), ILLNESS (got sick), EXERCISE TOLERANCE DECREASED (never able to run with the same cardiovascular capacity), JOINT INJURY (joint injuries) and ARTHRALGIA (joint pain). On an unknown date, the patient experienced PAIN (having aches) and DYSPNOEA (they can not get a breath,run out of breath). At the time of the report, PAIN (having aches) had not resolved and VACCINATION COMPLICATION (rapid health decline), ILLNESS (got sick), EXERCISE TOLERANCE DECREASED (never able to run with the same cardiovascular capacity), JOINT INJURY (joint injuries), DYSPNOEA (they can not get a breath,run out of breath) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: did not feel too good either; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (did not feel too good either) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced FEELING ABNORMAL (did not feel too good either). At the time of the report, FEELING ABNORMAL (did not feel too good either) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant drugs were not reported. Treatment medications were not provided.   This case was linked to MOD-2022-456197 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: blood sugar 162/blood sugar 130; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (blood sugar 162/blood sugar 130) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041J21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 18-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2022, the patient experienced BLOOD GLUCOSE INCREASED (blood sugar 162/blood sugar 130). At the time of the report, BLOOD GLUCOSE INCREASED (blood sugar 162/blood sugar 130) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2022, Blood glucose: 162 162. On 20-Jan-2022, Blood glucose: 130 130.         Concomitant medications were not reported. Treatment medications were not reported. Before she got her booster dose the patient blood sugar was 115.   This case was linked to MOD-2022-456189 (Patient Link).
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: got an expired first dose of the vaccine/just noticed the expiry date was 01Oct2021; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got an expired first dose of the vaccine/just noticed the expiry date was 01Oct2021) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (got an expired first dose of the vaccine/just noticed the expiry date was 01Oct2021). On 08-Oct-2021, EXPIRED PRODUCT ADMINISTERED (got an expired first dose of the vaccine/just noticed the expiry date was 01Oct2021) had resolved.            Concomitant drugs were not reported. Treatment medications were not provided.   This case was linked to MOD-2022-456443 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: reaction; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reaction). At the time of the report, VACCINATION COMPLICATION (reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Age: 55.0
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity, Skin disorder, Skin irritation
Clinical narrative: irritation; breakage; allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (irritation), SKIN DISORDER (breakage) and HYPERSENSITIVITY (allergic reaction) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 045B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SKIN IRRITATION (irritation), SKIN DISORDER (breakage) and HYPERSENSITIVITY (allergic reaction). At the time of the report, SKIN IRRITATION (irritation), SKIN DISORDER (breakage) and HYPERSENSITIVITY (allergic reaction) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication was not provided. Treatment information was not provided.   This case was linked to MOD-2022-456314, MOD-2022-456311 (Patient Link).
Age: 55.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site pain
Clinical narrative: to lift their arm above their head, move it, or do anything with it; arm pain in the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (to lift their arm above their head, move it, or do anything with it) and VACCINATION SITE PAIN (arm pain in the injection arm) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2022, the patient experienced VACCINATION SITE PAIN (arm pain in the injection arm). On 15-Jan-2022, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (to lift their arm above their head, move it, or do anything with it). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (to lift their arm above their head, move it, or do anything with it) and VACCINATION SITE PAIN (arm pain in the injection arm) outcome was unknown.            No concomitant medications were reported. Patient had received a prescription for steroids from their HCP, but have not taken the steroids at this point. Patient declined gender information and informed is not pregnant.   This case was linked to MOD-2022-456291, MOD-2022-456311 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles since Halloween of 2021; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles since Halloween of 2021) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced HERPES ZOSTER (shingles since Halloween of 2021). At the time of the report, HERPES ZOSTER (shingles since Halloween of 2021) had not resolved.            Patient had 1st and 2nd Moderna dose "earlier in year of 2021" No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.   Reporter did not allow further contact
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: A 16 year old female patient was inadvertently  administered with the Moderna Vaccine as booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 16 year old female patient was inadvertently  administered with the Moderna Vaccine as booster dose) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 16 year old female patient was inadvertently  administered with the Moderna Vaccine as booster dose). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 16 year old female patient was inadvertently  administered with the Moderna Vaccine as booster dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Bedridden, Chills, Diarrhoea, Dizziness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Had a high fever (up and down) for 10 days) on 16-Aug-2020 and Physical therapy (And pain management treatment on her neck due to COVID-19, as it took 14 days to recover from it). Concurrent medical conditions included Drug allergy (Sulfa) and Adhesive tape allergy. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm). At the time of the report, HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient stated that she was taking a lot of medications to treat various medical conditions and did not reported the medications. No treatment information was provided by the reporter. This case was linked to MOD-2022-456426, MOD-2022-456401 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeding disorder, Feeling abnormal, Feeling hot, Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Had a high fever (up and down) for 10 days) on 16-Aug-2020 and Physical therapy (And pain management treatment on her neck due to COVID-19, as it took 14 days to recover from it). Concurrent medical conditions included Drug allergy (Sulfa) and Adhesive tape allergy. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm). At the time of the report, HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient stated that she was taking a lot of medications to treat various medical conditions and did not reported the medications. No treatment information was provided by the reporter. This case was linked to MOD-2022-456426, MOD-2022-456401 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Influenza like illness, Loss of personal independence in daily activities, Nasopharyngitis, Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Had a high fever (up and down) for 10 days) on 16-Aug-2020 and Physical therapy (And pain management treatment on her neck due to COVID-19, as it took 14 days to recover from it). Concurrent medical conditions included Drug allergy (Sulfa) and Adhesive tape allergy. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm). At the time of the report, HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient stated that she was taking a lot of medications to treat various medical conditions and did not reported the medications. No treatment information was provided by the reporter. This case was linked to MOD-2022-456426, MOD-2022-456401 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin discolouration, Tremor
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Had a high fever (up and down) for 10 days) on 16-Aug-2020 and Physical therapy (And pain management treatment on her neck due to COVID-19, as it took 14 days to recover from it). Concurrent medical conditions included Drug allergy (Sulfa) and Adhesive tape allergy. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm). At the time of the report, HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient stated that she was taking a lot of medications to treat various medical conditions and did not reported the medications. No treatment information was provided by the reporter. This case was linked to MOD-2022-456426, MOD-2022-456401 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypokinesia, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Had a high fever (up and down) for 10 days) on 16-Aug-2020 and Physical therapy (And pain management treatment on her neck due to COVID-19, as it took 14 days to recover from it). Concurrent medical conditions included Drug allergy (Sulfa) and Adhesive tape allergy. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm). At the time of the report, HYPOKINESIA (Difficulty lifting left arm up) and PAIN IN EXTREMITY (Sore left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient stated that she was taking a lot of medications to treat various medical conditions and did not reported the medications. No treatment information was provided by the reporter. This case was linked to MOD-2022-456426, MOD-2022-456401 (Patient Link).
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: sore arm/body aches; mild fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm/body aches) and PYREXIA (mild fever) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced MYALGIA (sore arm/body aches) and PYREXIA (mild fever). At the time of the report, MYALGIA (sore arm/body aches) and PYREXIA (mild fever) outcome was unknown.            No concomitant and treatment medication were reported. The patient had a sore arm, a mild fever and had body aches.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Pruritus, Rash pruritic
Clinical narrative: also experiencing itches on gluteus and elbows; patient feels confused; itchy rash appeared on her legs, on the outside of the thighs; slight itching in her legs and back; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (slight itching in her legs and back), RASH PRURITIC (itchy rash appeared on her legs, on the outside of the thighs), PRURITUS (also experiencing itches on gluteus and elbows) and CONFUSIONAL STATE (patient feels confused) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Blood pressure high and Candida infection. Concomitant products included LISINOPRIL for Blood pressure high, METFORMIN for Diabetes.    On 13-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2022, the patient experienced PRURITUS (slight itching in her legs and back). On 16-Jan-2022, the patient experienced RASH PRURITIC (itchy rash appeared on her legs, on the outside of the thighs). On an unknown date, the patient experienced PRURITUS (also experiencing itches on gluteus and elbows) and CONFUSIONAL STATE (patient feels confused). At the time of the report, PRURITUS (slight itching in her legs and back), RASH PRURITIC (itchy rash appeared on her legs, on the outside of the thighs), PRURITUS (also experiencing itches on gluteus and elbows) and CONFUSIONAL STATE (patient feels confused) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported that she is not sure about what caused rash, because she explained started taking a naturopathic pills for Candida around the same time as the booster, but she stop medication when she noticed about rash. No treatment has been given.   This case was linked to MOD-2022-456397 (Patient Link).
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Rash
Clinical narrative: had flu like symptoms; had a rash on his feet & ankles that looked like eczema or poison ivy that last about a week/was more on his left than right foot; was sore for a day; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (had flu like symptoms), RASH (had a rash on his feet & ankles that looked like eczema or poison ivy that last about a week/was more on his left than right foot) and MYALGIA (was sore for a day) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (had flu like symptoms), RASH (had a rash on his feet & ankles that looked like eczema or poison ivy that last about a week/was more on his left than right foot) and MYALGIA (was sore for a day). At the time of the report, INFLUENZA LIKE ILLNESS (had flu like symptoms), RASH (had a rash on his feet & ankles that looked like eczema or poison ivy that last about a week/was more on his left than right foot) and MYALGIA (was sore for a day) outcome was unknown.            No concomitant drug details were reported. No treatment details were reported.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: an expired dose (beyond use date) of modena was administered on 19-jan-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (an expired dose (beyond use date) of modena was administered on 19-jan-2022) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (an expired dose (beyond use date) of modena was administered on 19-jan-2022). On 19-Jan-2022, EXPIRED PRODUCT ADMINISTERED (an expired dose (beyond use date) of modena was administered on 19-jan-2022) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: diarrhea; nausea; This spontaneous case was reported by a physician and describes the occurrence of DIARRHOEA (diarrhea) and NAUSEA (nausea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced DIARRHOEA (diarrhea) and NAUSEA (nausea). At the time of the report, DIARRHOEA (diarrhea) and NAUSEA (nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Influenza
Clinical narrative: Flu; Headache; Sore joints; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA (Flu), HEADACHE (Headache) and ARTHRALGIA (Sore joints) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced INFLUENZA (Flu), HEADACHE (Headache) and ARTHRALGIA (Sore joints). At the time of the report, INFLUENZA (Flu), HEADACHE (Headache) and ARTHRALGIA (Sore joints) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (fever), CHILLS (chill) and MYALGIA (body ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2022, the patient experienced PYREXIA (fever), CHILLS (chill) and MYALGIA (body ache). At the time of the report, PYREXIA (fever), CHILLS (chill) and MYALGIA (body ache) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue discomfort, Tongue pruritus
Clinical narrative: like they burnt their tong on hot tea/having a taste on their tong; tong is scratchy; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DISCOMFORT (like they burnt their tong on hot tea/having a taste on their tong) and TONGUE PRURITUS (tongue is scratchy) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013H21B) for COVID-19 vaccination.     The patient's past medical history included Miscarriage and Hemorrhage (experienced it twice in the past). Concurrent medical conditions included Allergy to nuts (She has allergy to tree nuts, and 2 years ago her face blew up and she was hospitalized due to the allergy.). Concomitant products included VITAMINS NOS for an unknown indication.    On 29-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Dec-2021, the patient experienced TONGUE DISCOMFORT (like they burnt their tong on hot tea/having a taste on their tong) and TONGUE PRURITUS (tong is scratchy). At the time of the report, TONGUE DISCOMFORT (like they burnt their tongue on hot tea/having a taste on their tong) and TONGUE PRURITUS (tongue is scratchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present
Clinical narrative: Blood in the urine after booster; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD URINE PRESENT (Blood in the urine after booster) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Discoloration urine (sometimes patient's urine was a little pink in the past). Concurrent medical conditions included Factor VII deficiency.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD URINE PRESENT (Blood in the urine after booster). At the time of the report, BLOOD URINE PRESENT (Blood in the urine after booster) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.  Prior to the vaccination, the patient had not seen pink urine for a long time.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (little fever) and CHILLS (chills) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The patient's past medical history included Blood pressure management. Concurrent medical conditions included Diabetes and Anxiety. Concomitant products included DULOXETINE for Anxiety, AMLODIPINE for Blood pressure management, METFORMIN for Diabetes. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PYREXIA (little fever) and CHILLS (chills). On 23-Jan-2021, PYREXIA (little fever) and CHILLS (chills) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication included Centrum. On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (route of administration was unknown) 1 dosage form (batch number- 031M20A). The patient did not experience any symptom after second dose. No treatment information were given. This case was linked to MOD-2022-456589 (Patient Link).
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Head discomfort, Inappropriate schedule of product administration, Nasal discomfort, Pain in extremity
Clinical narrative: Head feels heavy; Nose feels weird; the muscle on the left arm there's pain; 50 days apart between 1st and 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Head feels heavy), NASAL DISCOMFORT (Nose feels weird), PAIN IN EXTREMITY (the muscle on the left arm there's pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50 days apart between 1st and 2nd dose) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50 days apart between 1st and 2nd dose). On an unknown date, the patient experienced HEAD DISCOMFORT (Head feels heavy), NASAL DISCOMFORT (Nose feels weird) and PAIN IN EXTREMITY (the muscle on the left arm there's pain). On 20-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50 days apart between 1st and 2nd dose) had resolved. At the time of the report, HEAD DISCOMFORT (Head feels heavy), NASAL DISCOMFORT (Nose feels weird) and PAIN IN EXTREMITY (the muscle on the left arm there's pain) had not resolved.            No concomitant medications were reported. The patient had been experienced some medical issues after vaccination. Outcome of the events were reported as still ongoing. No treatment medications were reported.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in the arm; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Sjogren's (Sjogren's (kind of a lupus)).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (Soreness in the arm). At the time of the report, PAIN IN EXTREMITY (Soreness in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The reporter stated that the patient received their first dose on 03-Mar-2021 and experienced soreness in the arm. It was also reported that the patient had preexisting medical condition Sjogren's (kind of a lupus) with unknown onset, but the patient confirmed it was prior to the vaccine.  No treatment information was provided.   This case was linked to MOD-2022-456751, MOD-2022-456752 (Patient Link).
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Influenza like illness, Pyrexia
Clinical narrative: Flu like symptoms; Fever of 101.5 degrees Farenheight; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Fever of 101.5 degrees Farenheight) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A, 039B21A and 034F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Fever of 101.5 degrees Farenheight). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Fever of 101.5 degrees Farenheight) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-May-2021, Body temperature: 101.5 (High) 101.5 degrees Farenheight..         No concomitant products were reported.   No treatment information was reported.   This case was linked to MOD-2022-456661 (Patient Link).
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Malaise, Myalgia, Pyrexia
Clinical narrative: felt pretty rotten for 2 days; had a mild temperature, around 99-100F; sore arm at injection site; pretty strong body aches; felt very run down; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt pretty rotten for 2 days), PYREXIA (had a mild temperature, around 99-100F), VACCINATION SITE PAIN (sore arm at injection site), MYALGIA (pretty strong body aches) and FATIGUE (felt very run down) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.  On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced MALAISE (felt pretty rotten for 2 days), PYREXIA (had a mild temperature, around 99-100F), VACCINATION SITE PAIN (sore arm at injection site), MYALGIA (pretty strong body aches) and FATIGUE (felt very run down). In April 2021, MALAISE (felt pretty rotten for 2 days) had resolved. At the time of the report, PYREXIA (had a mild temperature, around 99-100F), VACCINATION SITE PAIN (sore arm at injection site), MYALGIA (pretty strong body aches) and FATIGUE (felt very run down) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Body temperature: 99-100 (High) mild temperature, around 99-100F.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No Concomitant medications were reported. No Treatment information was reported.   This case was linked to MOD-2022-455755, MOD-2022-455756 (Patient Link).
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: felt pretty rotten for 2 days; had a mild temperature, around 99-100F; sore arm at injection site; pretty strong body aches; felt very run down; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt pretty rotten for 2 days), PYREXIA (had a mild temperature, around 99-100F), VACCINATION SITE PAIN (sore arm at injection site), MYALGIA (pretty strong body aches) and FATIGUE (felt very run down) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.  On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced MALAISE (felt pretty rotten for 2 days), PYREXIA (had a mild temperature, around 99-100F), VACCINATION SITE PAIN (sore arm at injection site), MYALGIA (pretty strong body aches) and FATIGUE (felt very run down). In April 2021, MALAISE (felt pretty rotten for 2 days) had resolved. At the time of the report, PYREXIA (had a mild temperature, around 99-100F), VACCINATION SITE PAIN (sore arm at injection site), MYALGIA (pretty strong body aches) and FATIGUE (felt very run down) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Body temperature: 99-100 (High) mild temperature, around 99-100F.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No Concomitant medications were reported. No Treatment information was reported.   This case was linked to MOD-2022-455755, MOD-2022-455756 (Patient Link).